DARE vs UTHR · rev $187.5K vs P/E 20, rev $1.56B
Dare Bioscience Inc (DARE) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Dare Bioscience Inc (DARE) is a biotechnology company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported DARE revenue for 2026-06-30 was $187.5K. Net income was -$3.0M. Revenue was up 23.0% from 2026-03-31 to 2026-06-30. DARE currently screens at market cap $21.2M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
DARE currently screens at market cap $21.2M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the DARE and UTHR stock pages for the full models.
Not investment advice.